Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 818 results for "bristol myers squibb"

NICE limits use of BMS's Daklinz to treat hepatitis C infection in UK
Pharmaceutical Technology

NICE limits use of BMS's Daklinz to treat hepatitis C infectio...

The National Institute for Health and Care Excellence (NICE) has limited the use of Bristol-Myers Squibb's (BMS) Daklinza (daclatasvir) to treat adult patients with chronic hepatitis C infection in the UK. According to the published data, ... Pharmaceutical Technology, 20 hours ago
[x]  

Bristol Myers (BMY) Showing Support Near $63.89

The patented algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center found a trading opportunity with Bristol-Myers Squibb Co (http://www.marketintelligencecenter.com/symbol/BMY"BMY) that should provide a 2.11% return in ...
 Individual.com17 hours ago Bristol-Myers Squibb PT Raised to $77.00 (BMY)  Mideast Time16 hours ago Bristol-Myers Squibb Given Buy Rating at Leerink Swann (BMY)  Ticker Report1 day ago Bristol-Myers Squibb Price Target Increased to $77.00 by Analysts at Leerink Swann (BMY)  Ticker Report2 days ago
[x]  

Look for Shares of Bristol-Myers Squibb to Potentially Rebound after Yesterday's 2.55% Sell Off

(Comtex SmarTrend(R)) Bristol-Myers Squibb (NYSE:BMY) traded in a range yesterday that spanned from a low of $64.29 to a high of $65.70. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $65.98 on volume of 8.1 ...
 Individual.com2 days ago SmarTrend Watching for Potential Rebound in Shares of Bristol-Myers Squibb After 2.55% Loss  Individual.com2 days ago

Album launched to promote World Hepatitis Day

For the fifth World Hepatitis Day on July 28, Wu Jieping Medical Foundation and Bristol-Myers Squibb, a global biopharma company, have launched China's first picture album to record the 10-year history of hepatitis B treatment in China. The album ...
 CHINAdaily USA2 days ago BRISTOL MYERS SQUIBB : Album launched to promote World Hepatitis Day  4 Traders2 days ago Oman health: Stress on Hepatitis C awareness on World Hepatitis Day  Times of Oman1 day ago Seven FDA developments since last World Hepatitis Day  Orthopedics Today1 day ago
[x]  
Motley Fool

Is Bristol-Myers Squibb Outpacing Johnson & Johnson?

Source: Flickr user Paul A race for dominance in the anticoagulant market is heating up between Bristol-Myers Squibb (NYSE: BMY) and Johnson & Johnson (NYSE: JNJ) with the winner standing to reap billions of dollars in additional revenue over the ...
 Motley Fool4 days ago
[x]  
FOXNews.com

Bristol-Myers Halts Trial Early After Kidney Cancer Success

Bristol-Meyers Squibb Co. stopped a clinical trial of its drug Opdivo six months early after the therapy kept kidney-cancer patients alive longer compared with those taking a standard treatment. In the late-stage study of 821 patients who had ...
 Bloomberg1 week ago Bristol-Myers' Opdivo found effective in kidney cancer  Yahoo! India1 week ago Bristol's Opdivo found good at kidney cancer Reuters  NewsListOnline1 week ago UPDATE 1-Bristol-Myers' Opdivo found effective in kidney cancer  Reuters1 week ago
[x]  

MUSC and Bristol-Myers enter into research collaboration for fibrotic diseases

The Medical University of South Carolina, or MUSC, and Bristol-Myers Squibb Company have entered into a translational research collaboration focused on fibrotic diseases, including scleroderma, renal fibrosis and idiopathic pulmonary fibrosis. The ...
 Individual.com6 days ago Bristol Myers Squibb : MUSC and Bristol-Myers Squibb Update on Translational Research Collaboration Focused on Fibrotic Diseases  4 Traders1 week ago MUSC, Bristol-Myers Squibb ink translational research pact on fibrotic diseases  PharmaBiz1 week ago Bristol-Myers, MUSC to explore new treatments for fibrotic diseases  Pharmaceutical Business Review2 weeks ago
Miami Herald

Bristol-Myers wins approval for 1st hepatitis C type 3 drug

An experimental drug for one of the most difficult-to-treat types of hepatitis C has been approved by the Food and Drug Administration, adding to the surge of new options for patients with the liver-destroying virus. Daklinza (pronounced ...
 Miami Herald5 days ago Bristol-Myers wins FDA approval for first drug for tough-to-treat hepatitis C genotype 3  Canadian Business Magazine5 days ago Bristol-Myers Squibbs hepatitis C drug, Daklinza, receives FDA approval  Demanjo5 days ago 7/24/15 - Bristol-Myers wins FDA approval for first drug for tough-to-treat hepatitis C genotype 3  Pharmacy Choice5 days ago
[x]  
European Pharmaceutical Review

EMA accepts Bristol-Myers' Empliciti MAA under accelerated review

EMA accepts Bristol-Myers' Empliciti MAA under accelerated review 7/27/2015, 4:30 PM (Source: Seeking Alpha) The European Medicines Agency validates for review the Marketing Authorization Application (MAA) from ...
 TeleTrader.com2 days ago Bristol-Myers Says EMA Grants Accelerated Assessment Of MAA For Empliciti  Nasdaq2 days ago EMA grants accelerated assessment of MAA for Empliciti  European Pharmaceutical Review2 days ago Surging new drug sales highlight strong Bristol-Myers Q2  Yahoo! UK and Ireland6 days ago
[x]  
Jutia Group

UPDATE 2-AbbVie, Bristol-Myers get FDA nod for hep C treatments

(Adds Bristol-Myer Squibb's approval) July 24 (Reuters) - The U.S. Food and Drug Administration on Friday approved two treatments for less common forms of hepatitis C virus (HCV) infections. The regulator cleared AbbVie Inc's ...
 CNBC5 days ago Company Update: AbbVie Inc (NYSE:ABBV) AbbVie, Bristol-Myers get FDA nod for hep C treatments  Jutia Group5 days ago CORRECTED-UPDATE 2-AbbVie, Bristol-Myers get FDA nod for hep C treatments  Reuters UK5 days ago AbbVie, Bristol-Myers get FDA nod for hep C treatments  Yahoo! India5 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - bristol myers squibb
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less